Cannabis legalization is evolving.

Stay ahead of the curve. Get industry insights, expert perspectives, and the latest thinking on cannabis and workplace safety, research and policy trends delivered straight to your inbox.

Why recenTHC and why now?

Legacy drug testing types like urine, blood, and hair tests may punish people for past cannabis use instead of protecting the present. These test types can’t isolate recent THC use, leaving employers with little visibility into on-the-job safety and employees skeptical about cannabis testing.

We are focused on revolutionizing the landscape of substance detection, monitoring, and safety technology. Traditional drug testing types cannot tell the difference between what happened Saturday night and what happened Monday morning.

Our vision for the future of recent use cannabis testing is clear:

cannabis testing that separates personal choice from public risk.
cannabis testing that builds confidence in safe workplaces and protected communities.
cannabis testing that is fair and focused on recency of use.

Cannabis Risks by the Numbers

54%

Americans who live in a state where the recreational use of marijuana is legal¹

1+ in 25

U.S. employees test positive for cannabis during routine testing²

200%

Increase in workplace post-accident cannabis positivity rate between 2012-2022³

45.2%

Rate at which marijuana positivity has increased over five years⁴

Footnotes

¹DISA Global Solutions ²Quest 2022 Drug Testing Index ³Quest 2022 Drug Testing Index ⁴Quest 2023 Drug Testing Index

Fair. Effective. And a Force for Good.

Cannabis legalization is reshaping the modern workplace and employers are struggling to keep pace. Research is still catching up. Regulations and policy vary by state and the testing standards that once felt settled have been disrupted. The conversation around fair and effective cannabis testing is essential. We’re here to lead it.